While the treatment of atrial fibrillation has made many advancements in recent years there is still much more work to be done. As with other areas of medicine this includes individualized approaches to care.
Patients suffering from psoriasis have a higher risk of developing arrhythmia – even after controlling for other risk factors, according to a study published in the Journal of the American Academy of Dermatology.
A new review and meta-analysis finds that — despite the lack of drug-specific antidotes to arrest major bleeds — novel oral anticoagulants are associated with a lower risk of fatal bleeds than warfarin in patients with atrial fibrillation.
Atrial fibrillation is a growing problem and new techniques and technologies are being developed to treat the condition. One new device has been developed as a new surgical option for doctors to consider.
Analysis of continuous heart rhythm and outcome data indicates that temporary cases of atrial fibrillation (AF) do raise stroke risk — but the worst danger lasts only a few days after the heart returns to normal rhythm.